BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
Dyspnea News and Headlines
Dyspnea News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's
Dyspnea news alerts.
Site Map > Biotechnology News > Health News > Dyspnea
.

LILLY (ELI) & COMPANY: Asco Study - Non-Small Cell Lung Cancer with Alimta
FinanzNachrichten.de:  similar ...
ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed
TickerTech.com:  similar ...
ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed
KLFY:  similar ...
ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed
Bolsamania:  similar ...
ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed
Houston Chronicle:  similar ...
ASCO Study Confirms Importance of Histology in Treatment of Non-Small
FinanzNachrichten.de:  similar ...
ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed
Yahoo! Canada:  similar ...
Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008
Therapeutics Daily:  similar ...
Significant Data on ERBITUX(R) (cetuximab) and ImClone Pipeline to Be Presented at American Society of Clinica
Yahoo!:  similar ...
ERBITUX(R) (cetuximab) Data Demonstrate Improvements in Response Rate and Progression-Free Survival in Wild Ty
Yahoo!:  similar ...
ERBITUX(R) (cetuximab) Data Demonstrate Improvements in Response Rate and Progression-Free Survival in Wild Ty
Houston Chronicle:  similar ...
Significant Data on ERBITUX(R) (cetuximab) and ImClone Pipeline to Be Presented at American Society of Clinica
Houston Chronicle:  similar ...
Significant Data on ERBITUX(R) (cetuximab) and ImClone Pipeline to Be Presented at American Society of Clinica
Yahoo! Canada:  similar ...
ERBITUX(R) (cetuximab) Data Demonstrate Improvements in Response Rate and Progression-Free Survival in Wild Ty
Yahoo! Canada:  similar ...
Older chemotherapy regimens of little benefit for mesothelioma
Reuters Health:  similar ...
Sucampo Pharma Europe Receives Validation of Marketing Authorization Applications
Forbes.com:  similar ...
Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease We
Yahoo! Canada:  similar ...
Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease We
PR Newswire via Yahoo!:  similar ...
Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure
DiGiTAL50:  similar ...
Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure
KLFY:  similar ...

Search BioNews

      --- Advanced searching ---

 

Search BioWeb

      --- Advanced searching ---

 

BioPortfolio updates this list every 30 minutes so please bookmark and revisit regularly during the day:

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.